Sirona Biochem Corp. Share Price Other OTC
Equities
SRBCF
CA82967M1005
Biotechnology & Medical Research
Sales 2022 | 672K 489K 40.79M | Sales 2023 | 34.78K 25.33K 2.11M | Capitalization | 21.44M 15.62M 1.3B |
---|---|---|---|---|---|
Net income 2022 | -3M -2.19M -182M | Net income 2023 | -2M -1.46M -121M | EV / Sales 2022 | 48.8 x |
Net Debt 2022 | 48.04K 34.99K 2.92M | Net Debt 2023 | 1.61M 1.17M 97.79M | EV / Sales 2023 | 663 x |
P/E ratio 2022 |
-8.81
x | P/E ratio 2023 |
-8.43
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 89.41% |
Managers | Title | Age | Since |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 19/06/19 |
Director of Finance/CFO | - | 29/09/29 | |
Chief Tech/Sci/R&D Officer | - | 31/11/31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 19/06/19 |
Alex Marazzi
BRD | Director/Board Member | - | 19/06/19 |
Director of Finance/CFO | - | 29/09/29 |
1st Jan change | Capi. | |
---|---|---|
+48.67% | 56.69B | |
-2.76% | 41B | |
+35.88% | 38.11B | |
-11.22% | 26.89B | |
+9.25% | 25.59B | |
-23.10% | 18.59B | |
+1.88% | 12.39B | |
+26.43% | 11.99B | |
+21.74% | 11.88B |